EP 1235580 A2 20020904 - TRANSDERMAL SYSTEM CONTAINING ACETYLSALICYLIC ACID FOR TREATMENT OF MIGRAINE
Title (en)
TRANSDERMAL SYSTEM CONTAINING ACETYLSALICYLIC ACID FOR TREATMENT OF MIGRAINE
Title (de)
ACETYLSALICYLSÄURE ENTHALTENDES TRANSDERMALES SYSTEM ZUR BEHANDLUNG VON MIGRÄNE
Title (fr)
SYSTEME TRANSDERMIQUE CONTENANT DE L'ACIDE ACETYLSALICYLIQUE POUR LE TRAITEMENT DE LA MIGRAINE
Publication
Application
Priority
- DE 19959913 A 19991211
- EP 0012092 W 20001201
Abstract (en)
[origin: WO0141771A2] The use of acetylsalicylic acid for the treatment of migraine and other serotonin-dependent, thrombocyte-mediated diseases is characterised in that the effective agent is administered by means of a transdermal therapeutic system (TTS).
IPC 1-7
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/60 (2006.01); A61K 31/616 (2006.01); A61K 45/00 (2006.01); A61P 25/06 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR US)
A61K 9/7061 (2013.01 - EP US); A61K 31/616 (2013.01 - EP KR US); A61P 25/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 0141771A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0141771 A2 20010614; WO 0141771 A3 20011227; AU 2361801 A 20010618; CA 2393748 A1 20010614; DE 19959913 A1 20010628; EP 1235580 A2 20020904; JP 2003516356 A 20030513; KR 20020058087 A 20020712; US 2003008852 A1 20030109
DOCDB simple family (application)
EP 0012092 W 20001201; AU 2361801 A 20001201; CA 2393748 A 20001201; DE 19959913 A 19991211; EP 00987336 A 20001201; JP 2001543116 A 20001201; KR 20027007228 A 20020607; US 14920502 A 20020812